Harikrishna Nakshatri

University of Indianapolis

Full Professor(heuristic)

Cancer Cells and Metastasis · Oncology

Compare more Oncology professors.

h-index67
i10-index173
Publications715
Citations17,854

Grants

17 total · 6 active

NIH #I01BX007249

Mechanisms of physioxia-dependent cancer cell adaptation to targeted drugs along a resistance continuum

Active
Amount
Period
2025-10-012029-09-30
PIs
1

Awarded at RLR VA MEDICAL CENTER

NIH #P30CA082709

Cancer Research Training and Education Coordination

Active
Amount
$200K–$300K
Period
1999-09-222029-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #T32CA282070

Surgical Oncology Research Training at Indiana (SORTI)

Active
Amount
$500K–$600K
Period
2024-09-012029-08-31
PIs
2

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

17 total · 6 active

NIH #I01BX007249

Mechanisms of physioxia-dependent cancer cell adaptation to targeted drugs along a resistance continuum

Active
Amount
Period
2025-10-012029-09-30
PIs
1

Awarded at RLR VA MEDICAL CENTER

NIH #P30CA082709

Cancer Research Training and Education Coordination

Active
Amount
$200K–$300K
Period
1999-09-222029-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #T32CA282070

Surgical Oncology Research Training at Indiana (SORTI)

Active
Amount
$500K–$600K
Period
2024-09-012029-08-31
PIs
2

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #U01CA278865

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

Active
Amount
$300K–$400K
Period
2024-05-152029-04-30
PIs
2

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R25CA274184

Educational Pathways for Cancer Research (EPCR)

Active
Amount
$400K–$500K
Period
2023-09-192028-08-31
PIs
2

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R25CA269039

Summer Program for Academic Research in Cancer (SPARC)

Active
Amount
$200K–$300K
Period
2023-09-132028-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #IK6BX005244

BLR&D Research Career Scientist Award Application

Amount
Period
2020-04-012025-03-31
PIs
1

Awarded at RLR VA MEDICAL CENTER

NIH #R03CA223906

Impact of NF-kB methylation on chemoresistance and metastasis of breast cancer

Amount
<$100K
Period
2018-01-012020-12-31
PIs
2

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #I01BX002764

Mechanisms associated with systemic effects of cancer

Amount
Period
2015-04-012019-03-31
PIs
1

Awarded at RLR VA MEDICAL CENTER

NIH #R03CA195250

Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7

Amount
<$100K
Period
2015-12-042018-11-30
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R21CA159158

Persistent microRNA changes in serum of cancer-free breast cancer patients

Amount
$200K–$300K
Period
2011-03-092013-02-28
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R21CA152536

Anthrax Toxin Receptor as a marker and target of breast cancer stem cells

Amount
$200K–$300K
Period
2011-03-172013-02-28
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R03CA143994

Chemoprevention of tobacco carcinogen-induced bladder cancer

Amount
<$100K
Period
2010-09-012012-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #T32CA111198

Cancer Biology Training Program

Amount
$300K–$400K
Period
2005-04-012011-09-30
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R03CA137796

Lung Cancer Chemoprevention through LC-1

Amount
<$100K
Period
2008-09-152010-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R03CA117486

Animal Model for Local Inflammation-Induced Breast Cancer

Amount
<$100K
Period
2007-09-242009-08-31
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R03CA123561

Chemoprevention Through Activation of Estrogen Receptor Alpha-Induced Senescence

Amount
<$100K
Period
2006-07-112008-06-30
PIs
1

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

Recent Public Signals

  1. New paper: Influence of <i>TONSL</i> on tumor suppressor function of <i>RAD51</i> and resistance to CDK4/6 inhibitors in ER+ breast cancer. (Journal of Clinical Oncology)2026-05-27
  2. New NIH award: Mechanisms of physioxia-dependent cancer cell adaptation to targeted drugs along a resistance continuum2025-10-01
  3. New NIH award: Surgical Oncology Research Training at Indiana (SORTI)2024-09-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0001-8876-0052

Professor Insights

Career Trajectory